134 related articles for article (PubMed ID: 17279284)
21. Outcome of children with Langerhans cell histiocytosis and single-system involvement: A retrospective study at a single center in Shanghai, China.
Su M; Gao YJ; Pan C; Chen J; Tang JY
Pediatr Hematol Oncol; 2018; 35(7-8):385-392. PubMed ID: 30693828
[TBL] [Abstract][Full Text] [Related]
22. Treatment of Langerhans cell histiocytosis with a modified risk-adapted protocol-experience from a tertiary cancer institute in India.
Narula G; Pradhan ND; Arora B; Banavali SD
Pediatr Blood Cancer; 2018 Aug; 65(8):e27028. PubMed ID: 29512864
[TBL] [Abstract][Full Text] [Related]
23. Vinblastine chemotherapy in adult patients with langerhans cell histiocytosis: a multicenter retrospective study.
Tazi A; Lorillon G; Haroche J; Neel A; Dominique S; Aouba A; Bouaziz JD; de Margerie-Melon C; Bugnet E; Cottin V; Comont T; Lavigne C; Kahn JE; Donadieu J; Chevret S
Orphanet J Rare Dis; 2017 May; 12(1):95. PubMed ID: 28532436
[TBL] [Abstract][Full Text] [Related]
24. Pulmonary Langerhans cell histiocytosis: a variable disease in childhood.
Odame I; Li P; Lau L; Doda W; Noseworthy M; Babyn P; Weitzman S
Pediatr Blood Cancer; 2006 Dec; 47(7):889-93. PubMed ID: 16276522
[TBL] [Abstract][Full Text] [Related]
25. Intensified and prolonged therapy comprising cytarabine, vincristine and prednisolone improves outcome in patients with multisystem Langerhans cell histiocytosis: results of the Japan Langerhans Cell Histiocytosis Study Group-02 Protocol Study.
Morimoto A; Shioda Y; Imamura T; Kudo K; Kawaguchi H; Sakashita K; Yasui M; Koga Y; Kobayashi R; Ishii E; Fujimoto J; Horibe K; Bessho F; Tsunematsu Y; Imashuku S
Int J Hematol; 2016 Jul; 104(1):99-109. PubMed ID: 27040279
[TBL] [Abstract][Full Text] [Related]
26. Orbital involvement in langerhans cell histiocytosis.
Vosoghi H; Rodriguez-Galindo C; Wilson MW
Ophthalmic Plast Reconstr Surg; 2009; 25(6):430-3. PubMed ID: 19935242
[TBL] [Abstract][Full Text] [Related]
27. Outcome After Radiation Therapy for Langerhans Cell Histiocytosis Is Dependent on Site of Involvement.
Laird J; Ma J; Chau K; Chelius M; Shi W; Zhang Z; Lok BH; Yahalom J
Int J Radiat Oncol Biol Phys; 2018 Mar; 100(3):670-678. PubMed ID: 29413280
[TBL] [Abstract][Full Text] [Related]
28. Pediatric langerhans cell histiocytosis: single center experience over a 17-year period.
İnce D; Demirağ B; Özek G; Erbay A; Ortaç R; Oymak Y; Kamer S; Yaman Y; Kundak S; Vergin C
Turk J Pediatr; 2016; 58(4):349-355. PubMed ID: 28276205
[TBL] [Abstract][Full Text] [Related]
29. Craniospinal Langerhans cell histiocytosis in children: 30 years' experience at a single institution.
Davidson L; McComb JG; Bowen I; Krieger MD
J Neurosurg Pediatr; 2008 Mar; 1(3):187-95. PubMed ID: 18352762
[TBL] [Abstract][Full Text] [Related]
30. The 5-Year EFS of Multisystem LCH With Risk-Organ Involvement Is Suboptimal: A Single-center Experience From India.
Totadri S; Bansal D; Trehan A; Srinivasan R; Varma N; Kakkar N; Saxena AK; Bhatia P
J Pediatr Hematol Oncol; 2016 Jan; 38(1):e1-5. PubMed ID: 26274033
[TBL] [Abstract][Full Text] [Related]
31. Outcome of High-risk Langerhans Cell Histiocytosis (LCH) in Egyptian Children, Does Intermediate-dose Methotrexate Improve the Outcome?
Sedky MS; Hamouda A; Taha H; Zaky I; Hassanain O; El Hemaly A; ElHaddad A
J Pediatr Hematol Oncol; 2019 Nov; 41(8):635-643. PubMed ID: 30247183
[TBL] [Abstract][Full Text] [Related]
32. [Langerhans cell histiocytosis of the temporal bone: 22 cases analysis].
Chen L; Wang WQ; Xu H; Chi FL
Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2010 Mar; 45(3):212-6. PubMed ID: 20450701
[TBL] [Abstract][Full Text] [Related]
33. Langerhans' cell histiocytosis (histiocytosis X) of bone. A clinicopathologic analysis of 263 pediatric and adult cases.
Kilpatrick SE; Wenger DE; Gilchrist GS; Shives TC; Wollan PC; Unni KK
Cancer; 1995 Dec; 76(12):2471-84. PubMed ID: 8625073
[TBL] [Abstract][Full Text] [Related]
34. Long-term follow-up of Langerhans cell histiocytosis: 39 years' experience at a single centre.
Bernstrand C; Sandstedt B; Ahström L; Henter JI
Acta Paediatr; 2005 Aug; 94(8):1073-84. PubMed ID: 16188852
[TBL] [Abstract][Full Text] [Related]
35. Long-term outcome, clinical course and treatment approaches of paediatric langerhans cell histiocytosis: A greek reference centre report.
Tzotzola V; Petrikkos L; Papadakis V; Mitropoulou G; Kelaidi C; Dimitriadis E; Polychronopoulou S
Acta Paediatr; 2021 Jun; 110(6):1944-1951. PubMed ID: 33382132
[TBL] [Abstract][Full Text] [Related]
36. Langerhans' cell histiocytosis: head and neck manifestations in children.
Quraishi MS; Blayney AW; Walker D; Breatnach FB; Bradley PJ
Head Neck; 1995; 17(3):226-31. PubMed ID: 7782207
[TBL] [Abstract][Full Text] [Related]
37. [Treatment of langerhans cell histiocytosis in children].
Bilić E; Bojanić K; Pavlović M; Konja J; Femenić R; Dapić T; Antabak A; Anticević D; Murat-Susić S; Husar K; Potocki K; Rajić L
Lijec Vjesn; 2011; 133(11-12):376-84. PubMed ID: 22329293
[TBL] [Abstract][Full Text] [Related]
38. Improved outcome in the treatment of pediatric multifocal Langerhans cell histiocytosis: Results from the Japan Langerhans Cell Histiocytosis Study Group-96 protocol study.
Morimoto A; Ikushima S; Kinugawa N; Ishii E; Kohdera U; Sako M; Fujimoto J; Bessho F; Horibe K; Tsunematsu Y; Imashuku S;
Cancer; 2006 Aug; 107(3):613-9. PubMed ID: 16804933
[TBL] [Abstract][Full Text] [Related]
39. Differentiating skin-limited and multisystem Langerhans cell histiocytosis.
Simko SJ; Garmezy B; Abhyankar H; Lupo PJ; Chakraborty R; Lim KP; Shih A; Hicks MJ; Wright TS; Levy ML; McClain KL; Allen CE
J Pediatr; 2014 Nov; 165(5):990-6. PubMed ID: 25441388
[TBL] [Abstract][Full Text] [Related]
40. [Histiocytosis X--a retrospective analysis of 40 cases with localized or disseminated disease].
Kühl J; Kühner U; Ströder J
Monatsschr Kinderheilkd; 1984 Feb; 132(2):88-95. PubMed ID: 6610108
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
